Kestra Medical Technologies, Ltd.(KMTS)

$26.99—

Chart

Kestra Medical Technologies, Ltd.(KMTS)

NASDAQ

$26.99—

Chart Studio

KMTS(KMTS)

KMTS

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.62

Sep 10, 2026 · Reports after close

Revenue Estimate

$29M

Analyst Sentiment

Wall St. Consensus

Buy

4 analysts·Low coverage

Score

3 Buy (75%)1 Hold (25%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

375%

Hold

125%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$30.00

+11.2%

Consensus

$31.00

+14.9%

Bull

$32.00

+18.6%

12-Month Target Range4 analysts

$30.00$31.00$32.00

Current $26.99Consensus

Current Price

$26.99

Upside to Consensus

$4.01

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+47.38%

EPS—

FY2028

Rev+41.47%

EPS—

FY2029

Rev+29.37%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2027E	FY2028E	FY2029E
Revenue Avg	$137M	$194M	$251M
Low	$137M	$190M	$250M
High	$137M	$196M	$252M
EBITDA Avg	$-82M	$-116M	$-150M
Low	$-82M	$-118M	$-151M
High	$-82M	$-114M	$-150M
EBIT Avg	$-82M	$-116M	$-150M
Low	$-82M	$-118M	$-151M
High	$-82M	$-114M	$-150M
Net Income Avg	$-136M	$-121M	$-108M
Low	$-137M	$-128M	$-115M
High	$-132M	$-116M	$-102M
EPS Avg	$-2.30	$-2.07	$-1.83
Low	$-2.34	$-2.19	$-1.97
High	$-2.25	$-1.99	$-1.74
Analysts (Rev / EPS)	6 / 5	6 / 5	3 / 3

Quarterly

Metric	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028	Q3 2028
Revenue Avg	$32M	$35M	$41M	$42M	$45M	$49M	$58M	$40M
Low	$31M	$35M	$41M	$41M	$44M	$49M	$57M	$40M
High	$32M	$35M	$42M	$42M	$45M	$50M	$58M	$41M
EBITDA Avg	$-19M	$-21M	$-25M	$-25M	$-27M	$-30M	$-35M	$-24M
Low	$-19M	$-21M	$-25M	$-25M	$-27M	$-30M	$-35M	$-24M
High	$-19M	$-21M	$-25M	$-25M	$-27M	$-29M	$-34M	$-24M
EBIT Avg	$-19M	$-21M	$-25M	$-25M	$-27M	$-30M	$-35M	$-24M
Low	$-19M	$-21M	$-25M	$-25M	$-27M	$-30M	$-35M	$-24M
High	$-19M	$-21M	$-25M	$-25M	$-27M	$-29M	$-34M	$-24M
Net Income Avg	$-35M	$-33M	$-30M	$-32M	$-31M	$-30M	$-28M	$-33M
Low	$-36M	$-34M	$-30M	$-33M	$-31M	$-30M	$-28M	$-34M
High	$-33M	$-33M	$-30M	$-32M	$-31M	$-29M	$-27M	$-33M
EPS Avg	$-0.60	$-0.57	$-0.51	$-0.55	$-0.53	$-0.51	$-0.47	$-0.57
Low	$-0.62	$-0.58	$-0.52	$-0.56	$-0.54	$-0.51	$-0.48	$-0.58
High	$-0.56	$-0.56	$-0.51	$-0.54	$-0.52	$-0.50	$-0.47	$-0.56
Analysts (Rev / EPS)	6 / 3	5 / 1	5 / 1	5 / 1	5 / 1	2 / 1	2 / 1	2 / 1

Earnings Surprises

Recent Analyst Actions

Jul 15, 2026BTIG

Kestra Medical price target raised to $32 from $30 at BTIG

Target:$32.00

+32.3%from $24.18

Jul 15, 2026Wolfe Research

Kestra Medical Technologies (KMTS) PT Raised to $30 at Wolfe ResearchMember Login

Target:$30.00

+24.1%from $24.18

Jan 16, 2026Goldman Sachs

Kestra Medical price target lowered to $24 from $27 at Goldman Sachs

Target:$24.00

+4.4%from $22.98

Jan 9, 2026Goldman Sachs

Kestra Medical price target raised to $27 from $25 at Goldman Sachs

Target:$27.00

+1.3%from $26.65

Dec 13, 2025Goldman Sachs

Kestra Medical price target raised to $25 from $22 at Goldman Sachs

Target:$25.00

-4.7%from $26.22

Dec 12, 2025Stifel Nicolaus

Kestra Medical price target raised to $30 from $28 at Stifel

Target:$30.00

+13.1%from $26.52

Dec 12, 2025Wells Fargo

Kestra Medical price target raised to $28 from $27 at Wells Fargo

Target:$28.00

+12.1%from $24.97

Dec 12, 2025Piper Sandler

Kestra Medical price target raised to $30 from $27 at Piper Sandler

Target:$30.00

+20.1%from $24.97

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance